Yannic Laube
Biographic Data
| ID | 8450476 |
|---|---|
| NAME | Yannic Laube |
| GIVEN NAMES | Yannic |
| FAMILY NAME | Laube |
| SIGNATURE | LAUBE Y |
| AFFILIATIONS | University of Zurich |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Launch and Postlaunch Price Developments of New Drugs in the US, Germany, and Switzerland
The results of this cohort study suggest that, in contrast to Germany and Switzerland, prices of cancer drugs increased substantially post launch in the US. When developing solutions how drug prices can be decreased, launch as well as postlaunch prices require attention from policymakers
No prominent works on this page.
Launch and Postlaunch Price Developments of New Drugs in the US, Germany, and Switzerland
The results of this cohort study suggest that, in contrast to Germany and Switzerland, prices of cancer drugs increased substantially post launch in the US. When developing solutions how drug prices can be decreased, launch as well as postlaunch prices require attention from policymakers
Agency (philosophy (1 work) · Business (1 work) · Cohort (1 work) · Drug prices (1 work) · Economic and Financial Impacts of Cancer (1 work) · Economics (1 work) · Environmental health (1 work) · Food and drug administration (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work) · Internal Medicine (1 work)